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To investigate the eﬀect of intermittent high glucose (IHG) and sustained high glucose (SHG) on inducing β-cell apoptosis
and the potential involved mechanisms, INS-1 beta cells were incubated for 72h in the medium containing diﬀerent glucose
concentrations: control (5.5mmol/L), SHG (33.3mmol/L), and IHG (5.5mmol/L and 33.3mmol/L glucose alternating every
12h). Cell viability, apoptosis rate, and oxidative-stress markers were determined. The results showed that the apoptosis induced
by IHG was more obvious than that by SHG. Simultaneously, the intracellular level of oxidative stress was more signiﬁcantly
increased in INS-1 cells exposed to IHG. These ﬁndings suggest that intermittent high glucose could be more deleterious to β-cell
thana constanthigh concentrationof glucose, this maybe due to the aggravationof oxidative stress triggered by intermittent high
glucose.
1.Introduction
Apoptosis, an active process of cell suicide morphologically
and biochemically diﬀerent from necrosis and actively regu-
lated,playsan importantrolein thedevelopmentofdiabetes.
In recent years, the apoptosis of β-cells has become a major
focus. Several lines of evidence from autopsy suggested that
β-cell mass in diabetic patients is signiﬁcantly reduced and
its reduction is associated with increased apoptosis [1–3].
Both animal and human studies have found that increase of
β-cell apoptosis is an important reason of insulin deﬁciency
in patients with T2DM [1, 4]. So far, numerous evidences
have suggested that chronic persistent hyperglycemia results
in β-cells dysfunction and ultimately apoptosis, called β-
cell glucose toxicity [5]. However, the previous researches
mostly focused on the toxic eﬀect of persistent high glucose,
in fact, in addition to chronic persistent hyperglycemia,
another general and important phenomenon is the repeated
ﬂuctuation in blood glucose that existed in diabetes patients
which is more excessive than in healthy individuals [6].
Recently, a few published reports demonstrated the eﬀects
of intermittent high glucose on the development of diabetic
complications [7, 8], but the eﬀect of intermittent high
glucose on β-cell and the potential mechanisms involved
remain unknown.
There are many potential mechanisms whereby excess
glucose metabolites traveling along these pathways might
cause β-cell damage. However, all these pathways have in
common the formation of reactive oxygen species that cause
chronicoxidativestress, whichinturncausesincreasedapop-
tosis [9]. However, few reports show whether intermittent
high glucose triggers the oxidative stress within pancreatic
β-cell.
In the present study, we therefore aimed at analyzing the
role of intermittent high glucose in inducing β-cell apoptosis
and exploring the implications ofthe chronic oxidative stress
in this process.
2.Materialsand Methods
2.1. Chemicals. RPMI1640 medium and fetal bovine serum
were purchased from GIBCO. 2 ,7  -dichloroﬂuorescein di-
acetate (DCFH-DA), dimethyl sulphoxide (DMSO), 3-(4,
5-dimethylthialzal-z-yl)-2,5-diphenylterazolium bromide
(MTT), and Hoechst 33258 dye were purchased from Sigma,
Annexin V: FITC apoptosis detection kit was form BD.
Malondialdehyde (MDA) assay kit and glutathione (GSH)
assay kit were products of the Institute of Nanjing Jiancheng
Biology Engineering (Nanjing, China).2 Experimental Diabetes Research
2.2.β-Cell Culture. Dr.Tong-fengZhaokindlysuppliedINS-
1 cells. The cells were cultured in RPMI-1640 medium with
11mmol/L D-glucose supplemented with 10% fetal bovine
serum (FBS),100U/mL penicillin, 100μg/mL streptomycin,
10mmol/L HEPES, 2mmol/L L-glutamine, 1mmol/L so-
dium pyruvate, and 50μmol/L 2-mercaptoethanol. After
being cultured overnight in glucose-free RPMI 1640 with
5.5mmol/L glucose, INS-1 cells were divided into three
groups: (1) control group (CG) exposed to normal con-
centration of glucose (5.5mmol/L), (2) stable high glucose
(SHG)group exposed to 33.3mmol/L glucose, and (3) inter-
mittent high glucose (IHG) group exposed to ﬂuctuating
concentrations of glucose (alternating between 5.5mmol/L
and 33.3mmol/L glucoseevery 12h), and were incubatedfor
72h.
2.3. Cell Viability Assay. Cell viability was estimated by mea-
suring the metabolism of 3-(4, 5-dimethyldiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT). INS-1 cells were
seeded in 96-well microtiter plates with 1 × 103 per well and
incubated for 72h. At the end of the exposure, 20μLo f
MTT solution (5mg/mL) was added to each well, and cells
were maintained for 4h at 37◦C. After the supernatant ﬂuid
was removed, 150μL of solubilization solution (DMSO) was
added to each well and shaken for 10min. Absorbance was
measured at 570nm, with a microplate reader. Cell viability
w a se x p r e s s e da sap e r c e n t a g eo fcytoprotection, versus con-
trol group set at 100%.
2.4. Morphological Analysis by Hoechst 33258. To further
address the death pattern, INS-1 cells were stained with
a nuclear dye Hoechst 33258. The Hoechst 33258 ﬂuo-
rochrome is sensitive to chromatin and is used to assess the
changes in nuclear morphology. After exposure for 72h,
INS-1 cells were stained with Hoechst 33258 (5μg/mL) for
30min at room temperature in the dark. After washing three
times with phosphate-buﬀered saline, cells were visualized
and photographed under ultraviolet illumination using ﬂu-
orescent microscopy. Nuclear morphological changes char-
acteristic of apoptosis such as condensed or fragmented
nuclei with strong bright Hoechst 33258 dye staining were
observed. Ten random frames were imaged using ﬂuores-
cence microscope for each group, and the number of total
cells and apoptotic cells were obtained by counting. The
percentage of apoptotic cells was calculated as follows:
% apoptotic cells =
the number of apoptotic cells
the number of all cells
. (1)
2.5. Detection of Apoptotic Cells with Flow Cytometry. Apop-
tosis was assessed by annexin V-FITC and PI staining fol-
lowed by analysis with ﬂow cytometry. The methodology
followed the procedures as described in the kit. Brieﬂy, wash
cells twice with cold PBS. Resuspend cells in 1 × binding
buﬀer at a concentration of 1 × 106 cells/mL and transfer
100μL(1×105 cells)toa5mLculturetube.Thenadd5μLof
annexin V-FITC and 10μLo fP I .G e n t l yv o r t e xt h et u b ea n d
incubate for 15 minutes at room temperature in the dark.
Later, 400μLo f1× binding buﬀer was added to each tube.
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Figure 1: The cell viability in INS-1 cells. Cells were exposed to
normal glucose, stable high glucose, and intermittent high glucose
for72h. Theresults were presented asapercentage ofcontrol group
viability. Data were expressed as mean ± SD. ∗P<. 05 versus
control, ∗#P<. 05 versus SHG.
The stained cells were analyzed by ﬂow cytometry as soon as
possible (within an hour).
2.6. Measurement of Reactive Oxygen Species (ROS) Pro-
duction. The generation of ROS was measured using
an oxidation-sensitive ﬂuorescent probe 2 ,7  -dichlorodi-
hydroﬂuorescin diacetate (DCFH-DA). Intracellular esterase
activity results in the formation of DCFH, a nonﬂuorescent
compound, which emits ﬂuorescence when it is oxidized to
DCF. DCFH-DA has been widely used to measure the for-
mation of reactive species in cells [10]. Cells were incubated
with 20μMo fD C F H - D Af o r3 0 m i na t3 7 ◦C, and then
visualized under a ﬂuorescence microscope or analyzed by
ﬂow cytometry. Mean ﬂuorescence intensity was obtained.
2.7. Measurement of Malondialdehyde (MDA) and Glu-
tathione (GSH). The concentration of MDA was used as
an index of lipid peroxidation. Cells were lysed by an
ultrasoniccelldisruptorandcentrifugedat10000gat4◦Cfor
10min. MDA was determined as thiobarbituric acid reactive
substances (TBARS). In the assay, MDA reacts with thiobar-
bituric acid (TBA), yielding a stable chromophoric product
with maximal absorbance at 532nm. Results were expressed
as nmol MDA per mg of protein. Protein concentration was
determined by the BCA method (Beyotime, China).
Glutathione (GSH) concentration in the cells was mea-
suredusingtheglutathioneassaykitaccordingtotheinstruc-
tion manual. The method is based on the development of
a stable yellow color when 2-nitrobenzoic acid is added to
sulfhydryl compounds. The amount of reduced product,
thionitrobenzene, was measured at 412nm and expressed as
mg/gprot.
2.8. Statistical Analysis. All data were expressed as mean ±
SD. Diﬀerences among experimental groups were evaluated
by one-way analysis of variance (ANOVA), and the post hocExperimental Diabetes Research 3
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Figure 2: (a) Morphological assessment of apoptosis by Hoechst 33258 staining. Fluorescence microscope (400x) images. The arrowhead
indicates normal nuclei and blank arrows indicate apoptotic nuclei. (b) Assessment of apoptosis by Hoechst 33258 staining. Apoptosis rate
of each group was calculated as described in Section 2. The apoptosis rate was signiﬁcantly increased in IHG group. Data were expressed as
mean ± SD. ∗P<. 05 versus control, ∗#P<. 05 versus SHG.
test (Fisher’s PLSD) was used for multiple comparisons. Sig-
niﬁcance was deﬁned as P<. 05.
3.Results
3.1. IHG Decreased the Cell Viability in INS-1 Cells. The ef-
fect of IHG on cell viability in INS-1 cells was examined
using the MTT reduction assay. As shown in Figure 1,t h e
viability of INS-1 cells exposed to SHG and IHG was
signiﬁcantly reduced compared with control treatment (P<
.05). Furthermore, IHG induced more signiﬁcant decreases
in cell viability than SHG (P<. 05).
3.2. Morphological Assessment of Apoptosis by Hoechst 33258
Staining. As shown in Figure 2(a), in normal cells, the nuclei
exhibited dispersed and weak ﬂuorescence, the apoptotic
cells showed an apoptotic-like abnormal morphology (con-
densation and fragmentation) of nuclei and asymmetric
staining with Hoechst 33258. As illustrated in Figure 2(b),
after incubation for 72h, about 2.89 ± 2.26% of INS-1 cells
showed a typical cell apoptosis as revealed by typical chro-
matin condensation in control group. Cells incubated with
SHG and IHG revealed the marked condensed chromatin,
and the number was signiﬁcantly increased compared with
that of control group (P<. 05), with apoptosis rate 12.67 ±
1.41% and 19.33 ± 2.83%, respectively. These above results
indicated that the apoptotic rate in IHG group is higher than
SHG group.
3.3. Induction of Apoptosis in INS-1 Cells Measured by
Annexin-V/PI Staining via Flow Cytometry. The INS-1 cells
apoptosis was conﬁrmed by ﬂow cytometry. As shown in
Figure 3,thepercentageofapoptoticcellswas(2.79±0.96)%
in controlgroupwhile SHGand IHGincreased theapoptosis
rate to (13.12 ± 5.91)% and (23.66 ± 2.42)%, respectively.
IHG group showed statistical diﬀerences(P<. 05)compared
with the SHG group. That means intermittent high glucose
produced a signiﬁcant increase of cell apoptosis compared
with both normal and stable high glucose concentrations.
3.4. IHG Increased Reactive Oxygen Species Level. To evaluate
the inﬂuence of IHG on intercellular level of oxidative stress,
intracellular reactive oxygen species level was measured by
DCFH-DAﬂuorescencestaining.Asshown inFigure 4,when
INS-1 cells were exposed to SHG, the intracellular reactive
oxygen species level increased by 2.25-fold, more outstand-
ingly, the reactive oxygen species level signiﬁcantly increased
by 4.93-fold when exposed to IHG.
3.5. IHG Increased the MDA Concentration and Decreased
GSHConcentrationinINS-1Cells. AsshowninTable 1,SHG4 Experimental Diabetes Research
0
5
10
15
20
25
30
A
p
o
p
t
o
s
i
s
r
a
t
e
(
%
)
Control
Control
SHG
SHG
IHG
IHG
∗
∗#
Figure3:Detection ofapoptoticcellswithﬂowcytometry. Afterthe
treatment for 72h, cells were collected for the determination of cell
apoptosis as described previously. The percentage of apoptotic cells
was shown after analysis by ﬂow cytometry. Data were expressed
as mean ± SD of three determinations. ∗P<. 05 versus control,
∗#P<. 05 versus SHG.
and IHG treatment signiﬁcantly increased MDA concentra-
tion, and the concentration was higher in IHG group com-
pared to SHG group. The diﬀerence between two groups
was signiﬁcant (P<. 05). Compared to control treatment,
GSHconcentrationwasdecreasedwhenexposed toSHGand
IHG, but no signiﬁcant diﬀerences were found between two
groups.
4.Discussion
In the present study, we found that cultured INS-1 cells
exposedtohighglucoseconcentrationsshowedincreasedcell
apoptosis, and this eﬀect was further enhanced in cells that
were exposed to intermittent rather than sustained high glu-
cose. Furthermore, under the condition of IHG, the cellular
oxidative stress was more signiﬁcantly hyperactivated than
with SHG treatment. These ﬁndings suggest that variability
in glycemic control could be more deleterious to the INS-1
cells than a constant high glucose and oxidative stress may
play an important role in mediating this process.
It is now clear that hyperglycemia not only causes β-cell
dysfunction, but also induces β-cells apoptosis. Incubation
of human pancreatic islets in the presence of high glucose
concentrations and animal models with hyperglycemia has
repeatedly documented an increase of apoptotic rate [10–
15]. In the present study, evidence for apoptosis has been
obtained by several methods. All methods conﬁrm that high
glucose concentrations lead to increased β-cell apoptosis.
The result is in agreement with previous researches. More
importantly, we emphasized the eﬀect of ﬂuctuating hyper-
glycemia. Although in normal individuals plasma glucose
concentration is controlled strictly within a narrow range,
in patients with prediabetes or diabetes, the plasma glucose
Table 1: Mean values of concentrations ofMDA andGSH in INS-1
cells with diﬀerent intervention.
Group MDA (nmol/mgprot) GSH (mg/gprot)
Control 2.24 ± 0.41 45.50 ± 8.17
SHG 3.23 ± 0.73∗ 26.30 ± 10.73∗
IHG 4.38 ± 1.10∗# 25.51 ± 7.74∗
∗P<. 05 versus control, ∗#P<. 05 versus SHG.
concentration often changes markedly during the period of
as i n g l ed a y[ 6, 16, 17]. At present, evidences demonstrated
that intermittent high glucose may be more harmful than
stable high glucose in the development of diabetic car-
diovascular complications [18, 19]. Fluctuations of glucose
display a more dangerous eﬀect than stable high glucose
on both tubulointerstitial and mesangial cells, in terms of
cell proliferation [20, 21]. Similarly, compared to stable
high glucose, intermittent high glucose more signiﬁcantly
enhanced apoptosis in human umbilical vein endothelial
cells [22]. Consistently, our data showed that an intermittent
exposure to hyperglycemia led to more eﬀective induction
of apoptosis in INS-1 cells than a persistent exposure. Thus
cumulating evidence suggests that glucose variations may
be more dangerous for the cells than stable high glucose.
Recently, there are some evidences focused on the toxic
eﬀects of ﬂuctuating high glucose on islet beta cell functions
and survival [23, 24]. Del Guerra and his companions
obtained human pancreatic islets from nondiabetic and
nonobese multiorgan donors, and cultured them for 5 days
in continuous normal glucose concentration (5.5mmol/L)
ornormalandhigh(16.7mmol/L)glucoselevels(alternating
every 24h). They found that intermittent high glucose
caused a signiﬁcant decrease of glucose-stimulated insulin
secretion and apoptosis was also signiﬁcantly increased by
intermittent high glucose exposure [24]. In agreement with
Del Guerra et al.’s research, the present study also shows a
deleterious eﬀect of ﬂuctuating glucose for INS-1 cells. Fur-
ther comparing with stable high glucose, intermittent high
glucose induced higher apoptotic rates. Thus, results of the
present study and others indicate an important role for
intermittent high glucose in the pathology of DM.
Previousstudiesinvestigating theeﬀectsofglycemicvari-
ability on diabetic complications have explored the potential
mechanisms, such asthe role ofPKCand NAD(P)H-oxidase,
ICAM-1,VCAM-1, and E-selectin expression changes and
monocyte behavior [22, 25, 26]. Oxidative stress was con-
sidered to be one important mechanism involved. More
recently, El-Osta et al. [27] found that transient exposure of
aortic endothelial cells to hyperglycemia induced persistent
epigenetic changes in the promoter of the NF-κBp 6 5s u b -
unit. These epigeneticchanges were caused by increased gen-
eration of methylglyoxal because of hyperglycemia-induced
ROS formation. Toxic oxidative stress is also an important
reason for β-cell apoptosis [28]. It is particularly relevant
and dangerous for the islet, which is among those tissues
that have the lowest levels of intrinsic antioxidant defenses.
As the hyperglycemia of diabetes becomes chronic, the
sugar takes on the darker role of toxin and causes chronic
oxidative stress. The present study found that high glucoseExperimental Diabetes Research 5
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Figure 4: Demonstrationofintracellular ROS ofINS-1 cells with DCFH-DA staining.(a).Images ofDCFH-DA stainingforINS-1cells with
diﬀerent treatment. The graph (A) control group, (B) INS-1 cells exposed to stable high glucose, and (C) INS-1 cells exposed to intermittent
high glucose. (b). Data of DCFH-DA ﬂuorescence intensity analysis, ∗P<. 05 versus control, ∗#P<. 05 versus SHG.
produced an increase in oxidative stress generation. More-
over, it appears noteworthy that intermittent high glucose
enhances oxidative stress generationcompared to stable high
glucose. This is consistent with previous studies showing
that in patients with impaired glucose tolerance (IGT) and
diabetes, ﬂuctuation of plasma glucose concentration during
postprandial periods exhibited a more speciﬁc triggering
eﬀect on oxidative stress than sustained hyperglycemia [17,
29].
Theoxidativestress beingamajor mechanism forglucose
toxicity in beta cells has been suggested by previous studies.
High glucose concentrations increase the mitochondrial
proton gradient as a result of overproduction of electron
donors by the tricarboxylic acid cycle, which in turn increase
production of mitochondrial superoxide [9]. Several other
pathways of glucose metabolism such as glyceraldehyde
autoxidation pathway and hexosamine pathway are also
emphasized as being major contributors of ROS.
ROS can interact with nearby cellular components, such
as proteins, lipidse and DNA and results in wide-ranging
damage. Oxidative modiﬁcation of susceptible unsaturated
fatty acids can result in the generation of lipid peroxides,
and malondialdehyde (MDA) is one of them. GSH is one of
the primary defense systems against oxidative stress. So ROS,
MDA, and GSH can serve as markers of oxidative stress. In
this study, we selected themto evaluatethe levelsofoxidative
stress. Our data conﬁrmed that the potential mechanisms
involved in the toxic eﬀects of IHG on pancreatic β-cells
are, at least in part, the same as those working in stable
high glucose concentrations. However, they are enhanced in
intermittent high glucose condition.
In summary, our study suggested for the ﬁrst time that
chronic exposure to IHG led to more eﬀective induction
of apoptosis in INS-1 cells than SHG, which may be due
to excessive activation of cellular oxidative stress. In our
opinion, these data support the hypothesis that glucose
ﬂuctuation may be involved in β-cell injury. Moreover, our
data suggest that this phenomenon is partly related to the
activation of oxidative stress.
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